Sherene Loi

Sherene Loi

Peter Maccallum Cancer Centre - Melbourne / Australia
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4374989
-
person_outline Sherene Loi's MOST POPULAR ARTICLES
1-) Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancerP Schmid, S Adams, HS Rugo, A Schneeweiss, CH Barrios, H Iwata, ...New England Journal of Medicine 379 (22), 2108-2121, 201828612018
2-) The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, ...Annals of oncology 26 (2), 259-271, 201522932015
3-) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosisC Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ...Journal of the National Cancer Institute 98 (4), 262-272, 200622322006
4-) Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous …M Cristofanilli, NC Turner, I Bondarenko, J Ro, SA Im, N Masuda, ...The Lancet Oncology 17 (4), 425-439, 201618962016
5-) Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition …S Loi, N Sirtaine, F Piette, R Salgado, G Viale, F Van Eenoo, G Rouas, ...Journal of clinical oncology 31 (7), 860-867, 201318362013